Trial intelligence / Profile preview

Antenatal betamethasone for respiratory outcomes in late preterm neonates (34–37 weeks)

IRCT20120918010876N3Phase 2Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Mar 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of betamethasone in respiratory distress syndrome (RDS), sponsored by Shahid Beheshti University of Medical Sciences. Started Mar 2017; status: completed.

02

Drugs

betamethasone
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on IRCT20120918010876N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120918010876N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call